News

New research, published in ImmunoHorizons, paves the way for more personalized veterinary care for dogs that could help dog ...
Clonally expanded CD8+ T cells appear to play a causal role in the initiation and progression of alopecia areata.
T-cell receptor transgenic T cells (TCR-Ts) are the latest advancement in this field and are poised to play a central role in cellular cancer immunotherapies. Healio: Can you compare TCR-T with CAR-T?
Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused on the research and development of T cell receptor (TCR)-guided therapies for the ...
2022—Cellecta, Inc. today announced the launch of the DriverMap™ Adaptive Immune Receptor (AIR) TCR and BCR kits, a family of multiplex-PCR, NGS-based assays that enable profiling of up to all seven T ...
This study, published in Cell, demonstrates that engineering T-cells to express both a Chimeric Antigen Receptor (CAR) and a T-cell Receptor (TCR) can improve their ability to distinguish between ...
Background: Reports have demonstrated an inverse relationship between suppression of immune surveillance mechanisms and activation of the vascular endothelial growth factor receptor (VEGFR) pathway ...
Adaptive Biotechnologies lost a powerhouse partner after Roche subsidiary Genentech walked away from a potentially $2 billion ...
Genentech is continuing its summer of downsizing and cost-cutting, this time with plans to terminate a cell therapy deal ...